Herpes Simplex Keratitis Treatment Industry is expected to grow at a 6.1% CAGR, reaching a valuation of US$ 8,022.9 Million, according to the FMI study

Global herpes simplex keratitis treatment industry in 2022 was US$ 4,237.2 million and is estimated to be US$ 4,442.2 million in 2023. Future Market Insights has mentioned in its reports that the herpes simplex keratitis treatment industry will expand at a CAGR of 6.1% between 2023 and 2033, totaling around US$ 8,022.9 million by 2033. …